NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...
Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s disease. Here's what your doctor may recommend.